Esperion Therapeutics Inc (ESPR) — Long-term Investment Intensity
Esperion Therapeutics Inc (ESPR) has a Long-term Investment Intensity of 17.0% as of December 2022. Long-term investments of $42.09 Million represent 17.0% of total assets of $247.94 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Esperion Therapeutics Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Esperion Therapeutics Inc Long-term Investment Intensity (2013–2022)
This chart shows how Esperion Therapeutics Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2013 to 2022. As of December 2022, the intensity stands at 17.0%, reflecting long-term investments of $42.09 Million against total assets of $247.94 Million USD. For the complete balance sheet picture, see ESPR asset base.
Annual Long-term Investment Intensity for Esperion Therapeutics Inc (2013–2022)
The table below presents the year-by-year Long-term Investment Intensity for Esperion Therapeutics Inc from 2013 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Esperion Therapeutics Inc (ESPR) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 17.0% | $42.09 Million | $247.94 Million | ▲ +3.8 pp |
| 2021 | 13.2% | $50.44 Million | $381.59 Million | ▼ -2.9 pp |
| 2019 | 16.2% | $34.65 Million | $214.45 Million | ▲ +16.0 pp |
| 2018 | 0.2% | $243.00K | $143.45 Million | ▼ -26.3 pp |
| 2017 | 26.4% | $73.42 Million | $277.83 Million | ▲ +13.8 pp |
| 2016 | 12.6% | $30.91 Million | $245.21 Million | ▼ -14.6 pp |
| 2015 | 27.2% | $80.31 Million | $295.57 Million | ▲ +2.2 pp |
| 2014 | 24.9% | $35.74 Million | $143.34 Million | ▲ +2.5 pp |
| 2013 | 22.4% | $17.54 Million | $78.29 Million | — |